Atazanavir in pregnancy: 155 cases in London clinics
1 May 2011. Related: Conference reports, Antiretrovirals, Women's health, Pregnancy.
2011
Co-morbidity and late presentation – findings from an over 50s cohort
1 May 2011. Related: Conference reports.
Health outcomes for young adults with perinatally acquired HIV infection following transfer to adult services
1 May 2011. Related: Conference reports, Paediatric care.
The use of calcaneal stiffness index to screen for osteoporosis in HIV-infected individuals
1 May 2011. Related: Conference reports.
Frequency and characteristics of long-term non-progressors and HIV controllers in the Chelsea and Westminster cohort
1 May 2011. Related: Conference reports.
Cerebral function in perinatally HIV infected young people and HIV uninfected sibling controls
1 May 2011. Related: Conference reports.
An audit of HIV care provision for Immigration Removal Centre patients
1 May 2011. Related: Conference reports, Treatment access.
12th International Workshop on Clinical Pharmacology of HIV Therapy, 13-15 April 2011, Miami
1 May 2011. Related: Conference reports.
Quad reduces levels of oral contraceptives
1 May 2011. Related: Conference reports, Antiretrovirals, PK and drug interactions.
Elvitegravir/cobicistat and acid reducing agents
1 May 2011. Related: Conference reports, Antiretrovirals, PK and drug interactions.
Lopinavir/r reduces levels of rifabutin
1 May 2011. Related: Conference reports, Antiretrovirals, PK and drug interactions.
Cobicistat has little impact on CYP2D6 and CYP2B6
1 May 2011. Related: Conference reports, Antiretrovirals.
Atazanavir levels indicate need for higher dose during pregnancy
1 May 2011. Related: Conference reports, Antiretrovirals, Pregnancy.
Etravirine lowers levels of maraviroc given at 300 or 600 mg twice daily
1 May 2011. Related: Conference reports, Antiretrovirals.
Once-daily 150-mg maraviroc explored in people taking atazanavir/ritonavir
1 May 2011. Related: Conference reports, Antiretrovirals.
Lopinavir troughs lower in children on once-daily dose with efavirenz
1 May 2011. Related: Conference reports, Antiretrovirals, Paediatric care.
Dose optimisation: 50 mg ritonavir-boosting, 3TC dosing and raltegravir once-daily
1 May 2011. Related: Conference reports, Antiretrovirals, Treatment strategies.
46th European Association for the Study of the Liver (EASL), 30 March-3 April 2011, Berlin, Germany
1 May 2011. Related: Conference reports.
Rapid report: state of HCV policy, treatment, access
1 May 2011. Related: Conference reports, Antiretrovirals.
18th Conference on Retroviruses and Opportunistic Infections (CROI), 27 February-3 March 2011, Boston
1 May 2011. Related: Conference reports.
When to start ART in patients co-infected with TB: results from two trials presented at CROI
1 May 2011. Related: Conference reports, Antiretrovirals, TB coinfection.
Inflammation and intervention: how does HIV cause AIDS and how does it cause disease despite ART
1 May 2011. Related: Conference reports, Antiretrovirals.
Meeting report from 12th Pharmacology Workshop, Miami
1 May 2011. Related: PK and drug interactions.
Meeting report from 18th CROI, Boston
1 May 2011. Related: PK and drug interactions.
Atazanavir/ritonavir and combined oral contraceptives
1 May 2011. Related: PK and drug interactions.
BASHH/BHIVA PEPSE guidelines for comment (2011)
1 May 2011. Related: BHIVA news.
UK national guideline on safer sex advice
1 May 2011. Related: BHIVA news.
FEM-PrEP prevention study using daily Truvada halted during enrolment: interim analysis shows similar infection rates in active and placebo arms
1 May 2011. Related: HIV prevention and transmission.
Tenofovir associated with fewer side-effect related switches compared to AZT or d4T in first-line treatment
1 May 2011. Related: Side effects.
Reduced HIV replication in CD4 T cells from elite controllers
1 May 2011. Related: Basic science and immunology.
More studies on the loss of naive T cells
1 May 2011. Related: Basic science and immunology.
The immunological effects of old age and anti-CMV immunity in HIV infection
1 May 2011. Related: Basic science and immunology.
Community resources and publications
1 May 2011. Related: On the web.
Volume 12 Number 5/6 May/June 2011 PDF
1 May 2011. Related: PDFs.
Volume 12 Number 3/4 March/April 2011
1 April 2011. Related: Editorial.
18th Conference on Retroviruses and Opportunistic Infections (CROI), 27 February-3 March 2011, Boston
1 April 2011. Related: Conference reports.
New antiretrovirals: dolutegravir, entry inhibitor (BMS-663068) and tenofovir pro-drug (GS-7340)
1 April 2011. Related: Conference reports, Antiretrovirals.
Immune-based treatment increases HIV-resistant CD4 cells in phase 1 study
1 April 2011. Related: Conference reports, Antiretrovirals.
Antiretroviral prevention: oral PrEP, gels and treatment studies
1 April 2011. Related: Conference reports, Antiretrovirals.
Further efficacy analyses from the iPrEx study
1 April 2011. Related: Conference reports, Antiretrovirals.
Topical gels as PEP and PrEP: animal and human studies
1 April 2011. Related: Conference reports, Antiretrovirals.
Maternal risk following short course HAART
1 April 2011. Related: Conference reports, Antiretrovirals, Pregnancy.
Pre-term delivery and HAART
1 April 2011. Related: Conference reports, Antiretrovirals, Pregnancy.
HAART more effective than AZT monotherapy in the Botswana PMTCT programme
1 April 2011. Related: Conference reports, Antiretrovirals, Pregnancy.
Lopinavir/r monotherapy for PMTCT
1 April 2011. Related: Conference reports, Antiretrovirals, Pregnancy.
No evidence of increased risk of MTCT with sequential pregnancies in UK and Ireland
1 April 2011. Related: Conference reports, Pregnancy.
Recently infected women at the time of delivery have a higher rate of in-utero transmission in PEPI-Malawi
1 April 2011. Related: Conference reports, Pregnancy.
Reduced CCL22 concentrations in cervicovaginal secretions from pregnant women
1 April 2011. Related: Conference reports, Pregnancy.
First results from telaprevir in HIV/HCV coinfection
1 April 2011. Related: Conference reports, Antiretrovirals, Hepatitis coinfection.
HCV reinfection rates in HIV-positive gay men
1 April 2011. Related: Conference reports.
London HIV Consortium issues new guidelines for ARV prescribing (2011)
1 April 2011. Related: Antiretrovirals, Guidelines.
EMA issue restricted indication for d4T (stavudine)
1 April 2011. Related: Antiretrovirals.
Changes to starting dose of saquinavir in naive patients
1 April 2011. Related: Antiretrovirals.
FDA approve nevirapine XR
1 April 2011. Related: Antiretrovirals.
Lopinavir/r oral solution
1 April 2011. Related: Antiretrovirals.
Atazanavir use during pregnancy
1 April 2011. Related: Antiretrovirals, Pregnancy.
Nelfinavir interaction with warfarin
1 April 2011. Related: Antiretrovirals.
FDA approval of generic ARVs
1 April 2011. Related: Treatment access.
Global Fund reports rise in people on treatment
1 April 2011. Related: Treatment access.
UK increases funding to the Global Fund
1 April 2011. Related: Treatment access.
UK government development priorities and HIV
1 April 2011. Related: Treatment access.
Update on the Patent Pool
1 April 2011. Related: Treatment access.
TRIPS agreement flexibilities provide opportunities for improved access to ARVs
1 April 2011. Related: Treatment access.
Driving a decade of change: HIV/AIDS, patents and access to medicines for all
1 April 2011. Related: Treatment access.
Lower incidence of pregnancy in HIV positive compared to HIV negative women in the Womens Interagency HIV Study
1 April 2011. Related: Pregnancy.